Related Experiment Video
Updated: Aug 7, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
From idea to market: the drug approval process
1Department of Family Medicine, Northwestern University Medical School, Chicago, IL, USA.
The Journal of the American Board of Family Practice
|September 27, 2001
Summary
Understanding the Food and Drug Administration (FDA) drug approval process is crucial for physicians. This involves preclinical testing, clinical trials (phases 1-3), and postmarketing studies (phase 4).
Area of Science:
- Pharmaceutical Sciences
- Regulatory Affairs
- Clinical Medicine
Background:
- Numerous new prescription drugs receive Food and Drug Administration (FDA) approval annually.
- Understanding the drug development and approval pathway is essential for primary care physicians.
Purpose of the Study:
- To outline the comprehensive drug development and FDA approval process.
- To inform healthcare professionals about regulatory pathways for new medications.
Main Methods:
- Literature review and analysis of FDA websites detailing processes and policies.
- Description of the sequential stages in drug development and approval.
Main Results:
- Drug development encompasses preclinical testing, Investigational New Drug (IND) application, and multi-phase clinical trials (Phases 1-3).
- The New Drug Application (NDA) submission follows successful Phase 3 trials, with Phase 4 studies conducted post-approval.
- Recent legislative changes have expedited the FDA approval process, sparking debate on public safety versus patient access.
Conclusions:
- The drug approval process is a multi-stage journey from initial research to post-market surveillance.
- Balancing regulatory efficiency with public safety remains a key challenge in drug approval.
- Streamlined processes may improve access to critical medications for patients with severe diseases.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...